参考文献/References:
[1] Boden WE, O’rourke RA, Teo KK. Optimal medical therapy with or without PCI for stable coronary disease[J]. J Vasc Surg, 2007, 45(6):1503-1516..
[2] Cortigiani L, Bigi R, Sicari R. Is viability still viable after the STICH trial?[J]. Eur Heart J Cardiovasc Imaging, 2012, 13(3), 219-226.
[3] Arrighi JA, Dilsizian V. Multimodality imaging for assessment of myocardial viability:nuclear, echocardiography, MR, and CT[J]. Curr Cardiol Rep, 2012, 14(2):234-243.
[4] Sharir T, Germano G, Kang X, et al. Prediction of myocardial in-farction versus cardiac death by gated myocardial perfusion SPECT:Risk stratification by the amount of stress-induced is-chemia and the poststress ejection fraction[J]. J Nucl Med, 2001, 42(6):831-837.
[5] Rahimtoola SH. A perspective on the three large multicenter ran-domized clinical trials of coronary bypass surgery for chronic stable angina[J]. Circulation, 1985, 72(6Pt2):V123-135.
[6] Rahimtoola SH. The hibernating myocardium[J]. Am Heart J, 1989, 117(1):211-221.
[7] Braunwald E, Kloner RA. The stunned myocardium:prolonged, postischemic ventricular dysfunction[J]. Circulation, 1982, 66(6):1146-1149.
[8] Kloner RA, Ellis SG, Lange R, et al. Studies of experimental coro-nary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage[J]. Circula-tion, 1983, 68(2Pt2):8-15
[9] Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and as-sessment of myocardial viability[J]. Circulation, 2008, 117(1):103-114.
[10] Canty JM, Fallavollita JA. Hibernating myocardium[J]. J Nucl Car-diol, 2001, 125(1):104-119.
[11] Fallavollita JA, Riegel BJ, Suzuki G, et al. Mechanism of sudden cardiac death in pigs with viable chronically dysfunctional my-ocardium and ischemic cardiomyopathy[J]. Am J Physiol Heart Circ Physiol, 2005, 289(6):H2688-2696.
[12] 林振宇, 李殿富. 核素心肌灌注显像在冠心病中的应用进展[J]. 心血管病学进展, 2013, 34(5):626-630.
[13] 高玲, 贾鹏, 李爱梅. 核素心肌灌注显像测量心肌梗死大小临床应用分析[J]. 山西医药杂志:下半月刊, 2011, 10(20):1005-1006.
[14] 黄中柯, 楼岑, 史国华, 等. 99mTc-MIBI和18F-FDG双核素同步显像在心肌梗死诊疗中的价值[J]. 浙江大学学报:医学版, 2010, 39(5):530-533.
[15] Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography[J]. N Engl J Med, 1986, 314(14):884-888.
[16] Ling LF, Marwick TH, Flores DR et al. Identification of Therapeu-tic benefit from revascularization in patients with left ventricular systolic dysfunction:Inducible ischemia versus hibernating my-ocardium[J]. Circ Cardiovasc Imaging, 2013, 6(3):363-372.
[17] Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness criteria for coronary revascular-ization[J]. J Am Coll Cardiol, 2009, 53(6):530-553.
[18] Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update in-corporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults:A report of the Ameri-can College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation[J/OL]. J Am Coll Cardiol, 2009, 53(15):e1-90[2014-12-20]. http://www.ncbi.nlm.nih.gov/pubmed/19358937.
[19] Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guide-line for coronary artery bypass graft surgery. A report of the Ameri-can College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardio-vascular Anesthesiologists, and Society of Thoracic Surgeons[J/OL]. J Am Coll Cardiol, 2011, 58(24):e123-210[2014-12-20]. http://www.ncbi.nlm.nih.gov/pubmed/22070836.
[20] The task force on myocardial revascularization of the European So-ciety of Cardiology(ECS)and the European Association for Cardio-thoracic Surgery(EACTS). Guidelines on myocardial revasculariza-tion[J]. Eur Heart J, 2010, 31(20):2501-2555.
[21] Nekolla SG, Martinez-Moeller A, Saraste A. PET and MRI in car-diac imaging:from validation studies to integrated applications[J]. Eur J Nucl Med Mol Imaging, 2009, 36(Suppl 1):S121-130.
[22] D’Egidio G, Nichol G, Williams KA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocar-dial hibernation:A substudy of the PARR-2 trial[J]. JACC Cardio-vasc Imaging, 2009, 2(9):1060-1068.
[23] Abraham A, Nichol G, Williams KA, et al. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams:The Ottawa-FIVE substudy of the PARR 2 trial[J]. J Nucl Med, 2010, 51(4):567-574.
[24] Hillis GS, Zehr KJ, Williams AW, et al. Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting:Renal function and mortality after 3.8 years[J]. Circulation, 2006, 114(1):1414-1419.
[25] Cooper WA, O’Brien SM, Thourani VH, et al. Impact of renal dys-function on outcomes of coronary artery bypass surgery:Results from the Society of Thoracic Surgeons National Adult Cardiac Database[J]. Circulation, 2006, 113(8):1063-1070.
[26] 贾志新, 王全师, 陈伟华, 等. 13N-NH3, 18F-FDG PET显像在对心肌存活状况评估中的临床应用[J]. 中华血管病杂志, 2004, 32(1):9-12.
[27] 张晓丽, 刘秀杰, 吴清玉, 等. 18F-FDG心肌PET显像检测存活心肌的临床评价[J]. 中华核医学杂志, 1998, 18(4):196-198.
[28] Beanlands RS, Youssef G. Diagnosis and prognosis of coronary artery disease:PET is superior to SPECT:Pro[J]. J Nucl Cardiol, 2010, 17(4):683-695.
[29] Segall G. Assessment of myocardial viability by positron emission tomography[J]. Nucl Med Commun, 2002, 23(4):323-330.
[30] Knesaurek K, Machac J. Comparison of 18F SPECT with PET in my-ocardial imaging:a realistic thorax-cardiac phantom study[J]. BMC Nucl Med, 2006, 6:5.
[31] Slart RH, Bax JJ, van Veldhuisen DJ, et al. Prediction of functional recovery after evascularization in patients with chronic ischaemic left ventricular dysfunction:head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13Nammonia/18F-FDG PET[J]. Eur J Nucl Med Mol Imaging, 2006, 33(6):716-723.
[32] Tsai JP, Yun CH, Wu TH, et al. A meta-analysis comparing SPECT with PET for the assessment of myocardial viability in patients with coronary artery disease[J]. Nucl Med Comm, 2014, 35(9):947-954.
[33] Cerqueira MD. Diagnosis and prognosis of coronary artery disease:PET is superior to SPECT:Con[J]. J Nucl Cardiol, 2010, 17(4):678-682.
[34] Allman KC. Noninvasive assessment myocardial viability:current status and future directions[J]. J Nucl cardiol, 2013, 20(4):618-637.
[35] 黄钢, 石洪成. 心脏核医学[M]. 上海:上海科学技术出版社, 2011.
[36] Bonow RO, Holly TA. Myocardial viability testing:still viable af-ter stich?[J]. J Nucl Cardiol, 2011, 18(6):991-994.
[37] 侯凤丽, 支继新. 核素心肌灌注显像对缺血性心脏病的诊断作用[J]. 微循环学杂志, 2014, 24(2):77-79.
[38] Shaw LJ, Cerqueira MD, Brooks MM, et al. Impact of left ventricu-lar function and the extent of ischemia and scar by stress myocar-dial perfusion imagi ng on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease:Results from the bypass angioplasty revascularization investigation 2 diabetes(BARI 2D)trial[J]. J Nucl Cardiol, 2012, 19(4):658-669.
[39] 汪功勋, 包宗明. 核素心肌显像在存活心肌判定中的价值[J]. 医学综述, 2011, 17(1):122-124.
[40] Rischpler C, Nekolla S, Schwaiger M. PET and SPECT in heart fail-ure[J]. Curr Cardiol Rep, 2013, 15(3):337.
[41] Rischpler C, Nekolla SG, Dregely I, et al. Hybrid PET/MR imaging of the heart:Potential, initial experiences, and future prospects[J]. J Nucl Med, 2013, 54(3):402-415.
[42] Allman KC. Noninvasive assessment myocardial viability:current status and future directions[J]. J Nucl Cardiol, 2013, 20(4):618-637.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈越,李剑明.影像融合技术在冠心病中的临床应用进展[J].国际放射医学核医学杂志,2014,38(1):37.[doi:10.3760/cma.j.issn 1673-4114.2014.01.008]
Chen Yue,Li Jianming.Advances on the clinical applications of the image fusion techniques in coronary heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):37.[doi:10.3760/cma.j.issn 1673-4114.2014.01.008]
[3]张国建,王雪梅,刘艳阳.PET-CT在冠心病诊断中的临床应用及新进展[J].国际放射医学核医学杂志,2010,34(5):274.[doi:10.3760/cma.j.issn.1673-4114.2010.05.005]
ZHA NG Guo-jian,WANG Xue-mei,LIU Yan-yang.New progress and clinical application of PET-CT in coronary artery disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):274.[doi:10.3760/cma.j.issn.1673-4114.2010.05.005]
[4]孙启和,孙彬,杨永青.冠心病患者血清细胞因子和超敏C-反应蛋白水平测定的临床意义[J].国际放射医学核医学杂志,2010,34(5):291.[doi:10.3760/cma.j.issn.1673-4114.2010.05.010]
SUN Qi-he,SUN Bin,YANG Yong-qing.Clinical application of changes of serum cytokines and hypersensitive C-reactive protein in patients with coronary heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):291.[doi:10.3760/cma.j.issn.1673-4114.2010.05.010]
[5]邵晓梁,王跃涛.心肌灌注显像与冠状动脉钙化积分对冠心病风险评估的研究现状及相互关系[J].国际放射医学核医学杂志,2011,35(2):99.[doi:10.3760/cma.j.issn.1673-4114.2011.02.008]
SHA Xiao-liang,WANG Yue-tao.The progress of interrelationship between myocardial perfusion imaging and coronary artery calcium score in cardiac risk assessment[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(3):99.[doi:10.3760/cma.j.issn.1673-4114.2011.02.008]
[6]栾兆生,周雯,唐为国,等.99Tcm标记化合物显像检测冠心病的优化方案探讨[J].国际放射医学核医学杂志,2010,34(1):42.[doi:10.3760/cma.j.issn.1673-4114.2010.01.011]
LUAN Zhao-sheng,ZHOU Wen,TANG Wei-guo,et al.The optimal program of 99Tcm labeled radionuclide imaging in diagnosing coronary disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):42.[doi:10.3760/cma.j.issn.1673-4114.2010.01.011]
[7]杨波,刘长春,张勇,等.99Tcm-MIBI运动负荷-静息心肌灌注显像对冠心病患者经皮腔内冠状动脉血管成形术的疗效评价[J].国际放射医学核医学杂志,2009,33(1):37.[doi:10.3760/cma.j.issn.1673-4114.2009.01.037]
YANG Bo,LIU Chang-chun,ZHANG Yong,et al.Evaluation of the outcomes of 99Tcm-MIBI stress-rest perfusion imaging in coronary heart disease with percutaneous transluminal coronary angioplasty[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):37.[doi:10.3760/cma.j.issn.1673-4114.2009.01.037]
[8]张晓英,廖端芳.氡及其子体辐射诱发的非癌变效应[J].国际放射医学核医学杂志,2009,33(1):47.[doi:10.3760/cma.j.issn.1673-4114.2009.01.047]
ZHANG Xiao-ying,LIAO Duan-fang.Radon and its products radiation-induced non-cancerous effect[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):47.[doi:10.3760/cma.j.issn.1673-4114.2009.01.047]
[9]程艳,李思进,李险峰,等.99Tcm-NOET门控心肌灌注SPECT评价冠心病的价值[J].国际放射医学核医学杂志,2009,33(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.001]
CHENG Yah,LI Si-jin,LI Xian-feng,et al.Value of 99Tcm-NOET gated myocardial perfusion on patients with coronary heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):257.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.001]
[10]程旭,李殿富,徐兆强,等.冠心病影像学检查与辐射剂量[J].国际放射医学核医学杂志,2009,33(5):307.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.017]
CHENG Xu,LI Dian-fu,XU Zhao-qiang,et al.Radiation dose of cardiac diagnostic imaging in patients with coronary artery disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):307.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.017]